Direct-to-consumer advertising: The Campaign To Overturn Europe's Ban

A proposal by the European Commission to relax a ban on Direct-to-consumer advertising in Europe of prescription drug treaments for AIDS, asthma and diabetes was rejected in 2002 by the European Parliament and the Euopean COuncil in 2003.

Despite the result, the drug industry is hopeful that it will succeed in watering down the European Union ban on direct to consumer advertising (DTCA). Draft proposals from a working group, which includes members of the European Commission and the drug industry, have proposed a public private partnership to provide patient "information" on prescription medicines. [1] It is a prospect that horrifies the medical watchdog group, Health Action International (HAI). In response to the latest EU push, HAI stated that "the pharmaceutical industry is in no position to provide the information people want, need and deserve; information that is unbiased, reliable and comparative." In 2004 a push to weaken the EU's DTCA ban was overwhelmingly rejected. HAI report that one of the European Union members of parliament defended the latest move on the grounds that "70% of the current MEPs were new to their positions." [2] (pdf)

Despite this, Hannah Brown reports that in April 2007 proposals "that would jeopardise the current ban on direct-to-consumer advertising for prescription drugs" in the European Union will be unveiled by the European Commission, which drafts legislation for the European Parliament. [3] (Sub req'd)

It is expected that the commission will propose drug companies be allowed to provide 'information' while retaining the ban on product-specific advertising. "There is no discussion of whether industry is going to be an unbiased source about its own or other products or decisions not to treat," said Barbara Mintzes from the University of British Columbia. A coalition of public health groups opposing the anticipated changes argue that "relevant, comparative and appropriate information on health issues cannot be provided by drug companies" because they focus on promoting their product and ignore non-drug treatments. [4] (sub req'd).

SourceWatch Resources

• Drug industry
• Pharmaceutical Research and Manufacturers of America
• Direct-to-consumer advertising
• Direct-to-consumer advertising in the United States
• Direct-to-consumer advertising in New Zealand
• Direct-to-consumer advertising: CanWest's Bid to Overturn Canada's Ban
• Disease awareness campaigns
• European Commission High Level Pharmaceutical Forum
• Gunter Verheugen
• Jorgo Chatzimarkakis

External links

Articles In Academic Journals

• John Reast and Anna Carson, "UK Physicians attitudes towards direct to consumer advertising of prescription drugs: An exploratory analysis", International Journal of Advertising, 19, 200, pages 397-415.
• Les Toop and Dee Mangin, "Direct to consumer advertising: Industry funded patient information and the slippery slope to New Zealand", British Medical Journal, Volume 335, October 6, 2007, pp.694-695 (Sub req'd).

Submissions & Reports

• Social Audit, "Letter to EC consultation on advertising and electronic commerce", 2000.
• Health Action International Europe, International Society of Drug Bulletins, Association Internationale de la Mutualite, Bureau European des Unions de Consommateurs and Mediucines in Europe Forum, "Relevant Health Information For Empowered Citizens", October 2006. (Pdf)

General Articles

• Mark Hunter, "UK consumers reject direct advertising to patients by drug industry", British Medical Journal, June 2002.
• Claire Cozens, "Europe rejects drug advertising", The Guardian (UK), October 23, 2003.
• Rory Watson, "EU health ministers reject proposal for limited direct to consumer advertising", British Medical Journal, June 14, 2003.
• Andrew Jack, "Call to widen drugs information in Europe", MSNBC, September 28, 2006. (This story is originally from the UK-based Financial Times).
• Health Action International, "Direct-to-consumer advertising revisited by European commission, "Déjà-vu all over again"?", Media Release, October 4, 2006.
• Hannah Brown, "Advertising prescription drugs: Sweetening the pill", British Medical Journal, Volume 334, March 31, 2007. (Sub req'd)
• Ray Moynihan, "Citizens' alliance condemns EC report as "undocumented" and "biased"", British Medical Journal, June 23, 2007. (Sub req'd).

This article is a stub. You can help by expanding it.